Survival Analysing of the Breast Cancer Patients Using Cure Model

被引:2
作者
Bakhshi, Enayatollah [1 ]
Sheikhaliyan, Ayeh [2 ]
Atashgar, Keivan [2 ]
Kooshesh, Maryam [3 ]
Biglarian, Akbar [4 ]
机构
[1] Univ Social Welfare & Rehabil Sci, Dept Biostat, Biostat, Tehran, Iran
[2] Malek Ashtar Univ Technol, Dept Ind Engn, Ind Engn, Tehran, Iran
[3] Univ Tehran Med Sci, Tehran, Iran
[4] Univ Social Welfare & Rehabil Sci, Dept Biostat, Pediat Neurorehabil Res Ctr, Biostat, Tehran, Iran
关键词
Survival Analysis; Breast Cancer; Cox Proportional Hazards Models; Cured Model; RISK-FACTORS; WOMEN; RECURRENCES; METASTASES; RECEPTOR; THERAPY; IRAN;
D O I
10.5812/ircmj.55575
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Breast cancer (BC) is the most leading cause of cancer and the second most common cause of cancer-related death among females worldwide. The survival time of the disease and its risk factors are important for physicians. Objectives: The current study aimed at applying the Cox, cure, and frailty models to identify the risk factors related to the survival of patients with BC. Methods: The current historical cohort study investigated 499 patients with a confirmed diagnosis of BC, from March 2010 to March 2014, and followed-up to March 2015 in Besaat hospital in Tehran, Iran. The Cox regression, cure, and frailty models were used for the survival analysis (SA) of the patients. Data analysis was carried out by R3.2.2 software. Results: The mean (+/- SD) age of the patients was 50.39 (+/- 11.13) years and the mean survival time was 53.44 months (95% CI: 51.41-55.48). In addition, the 1-year overall survival ratewas0.92 (95% CI: 0.89-0.94). Ageat diagnosis, tumorsize, andmetastasis covariates were significant in all models (P < 0.05). Stage covariate were significant in frailty, cure, and failure time distribution model (P < 0.001). Familial history (P = 0.016) and pathology (P = 0.012) were significant only in the frailty model. Conclusions: The cure and frailty models were better than the Cox model to estimate the parameters. When some patients have a long-term survival, cure models can be an interesting method to study survival and also describe the short-term and long-term effects.
引用
收藏
页数:8
相关论文
共 37 条
  • [1] Abadi A, 2014, IRAN J CANCER PREV, V7, P124
  • [2] Abadi A, 2011, ASIAN PAC J CANCER P, V12, P3113
  • [3] Akhlaghi AA, 2013, J RES HEALTH SCI, V13, P32
  • [4] American Cancer Society, WHAT AR RISK FACT BR
  • [5] [Anonymous], 2014, WORLD CANC REPORT 20
  • [6] Baghestani Ahmad Reza, 2015, Asian Pac J Cancer Prev, V16, P7359
  • [7] Variables with time-varying effects and the Cox model: Some statistical concepts illustrated with a prognostic factor study in breast cancer
    Bellera, Carine A.
    MacGrogan, Gaetan
    Debled, Marc
    de lara, Christine Tunon
    Brouste, Veronique
    Mathoulin-Pelissier, Simone
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2010, 10
  • [8] Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European organization for research and treatment of cancer trial 10853
    Bijker, N
    Peterse, JL
    Duchateau, L
    Julien, JP
    Fentiman, IS
    Duval, C
    Di Palma, S
    Simony-Lafontaine, J
    de Mascarel, I
    van de Vijver, MJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) : 2263 - 2271
  • [9] Summary comments
    Cox, D. R.
    [J]. SURGICAL ONCOLOGY-OXFORD, 2010, 19 (02): : 61 - 61
  • [10] Defining prognosis for women with breast cancer and CNS metastases by HER2 status
    Dawood, S.
    Broglio, K.
    Esteva, F. J.
    Ibrahim, N. K.
    Kau, S. -W.
    Islam, R.
    Aldape, K. D.
    Yu, T. -K.
    Hortobagyi, G. N.
    Gonzalez-Angulo, A. M.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (07) : 1242 - 1248